Key partnership
Our partnership with CHUV plays a critical role in advancing our Rosalind Study. Their team conducts Xenium spatial transcriptomics analyses on our tumor samples, bringing single-cell resolution and precision to the heart of our research. Xenium's ability to map gene expression in tissue with subcellular accuracy is a game-changer for understanding the molecular signatures that set our exceptional cancer survivors apart.
The CHUV team and the Rosalind Trophy
The photo says it all: the CHUV team, holding the Rosalind trophy alongside a single cell Xenium sequencing machine from 10x Genomics, embodies the spirit of scientific ambition and collaboration that fuels our mission to reshape cancer care.
Thank you for your commitment, your expertise and your shared belief that cancer can be defeated.
Updated: May 11, 2026
